Phase II clinical trial - Sarcomes

BFR ESS 01
Sarcomes
Ouvert depuis le: 04.26.2024
Site: Paris
Public cible
Adulte
Randomized Comparative Prospective Multicentre Phase II Trial Evaluating Clinical Impact of Interruption VS Maintenance of AI in Patients With Locally Advanced/ Metastatic LGESS
Description de l'essai
The primary objective is to compare the progression-free survival (PFS) between aromatase inhibitors interruption and aromatase inhibitors maintenance strategies in patients with a locally advanced or metastatic Low Grade Endometrial Stromal Sarcoma (LGESS).
Liens utiles
Lien de l'essai
Vignette
SOPHIE PIPERNO-NEUMANN
Investigateur principal
Vignette
SOPHIE PIPERNO-NEUMANN
Investigateur principal